These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26295983)

  • 1. Laboratory developed tests in the clinical laboratory: challenges for implementation.
    Marzinke MA; Clarke W
    Bioanalysis; 2015; 7(15):1817-20. PubMed ID: 26295983
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results.
    Hickner J; Thompson PJ; Wilkinson T; Epner P; Sheehan M; Pollock AM; Lee J; Duke CC; Jackson BR; Taylor JR
    J Am Board Fam Med; 2014; 27(2):268-74. PubMed ID: 24610189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization management in toxicology.
    Zhang Y; Kwong TC
    Clin Chim Acta; 2014 Jan; 427():158-66. PubMed ID: 24091099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preface to the special edition of Clin Chem Acta: utilization management in the clinical laboratory.
    Lewandrowski K; Sluss P
    Clin Chim Acta; 2014 Jan; 427():107-8. PubMed ID: 24309229
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreasing inappropriate laboratory test utilization: controlling costs and improving quality of care.
    Wilson ML
    Am J Clin Pathol; 2015 May; 143(5):614-6. PubMed ID: 25873491
    [No Abstract]   [Full Text] [Related]  

  • 6. A perspective on laboratory utilization management from Canada.
    Naugler C
    Clin Chim Acta; 2014 Jan; 427():142-4. PubMed ID: 24084502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.
    Hillebrenner E; Litwack E; Bradley P; Donigan K; Lowe T; Serrano K; Kelm K; Mansfield E; Gutierrez A
    J Clin Pharmacol; 2015 Jul; 55(7):728-30. PubMed ID: 26053648
    [No Abstract]   [Full Text] [Related]  

  • 8. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance.
    Sidawy MK
    Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of informatics and decision support in utilization management.
    Baron JM; Dighe AS
    Clin Chim Acta; 2014 Jan; 427():196-201. PubMed ID: 24084507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory-Developed Tests: A Legislative and Regulatory Review.
    Genzen JR; Mohlman JS; Lynch JL; Squires MW; Weiss RL
    Clin Chem; 2017 Oct; 63(10):1575-1584. PubMed ID: 28687634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Laboratory Improvement Amendments of 1988 (CLIA); Fecal Occult Blood (FOB) Testing. Final rule.
    ;
    Fed Regist; 2017 Oct; 82(202):48770-3. PubMed ID: 29090890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening tuberculosis diagnosis in a low-resource setting: experience learned in Dodoma, Tanzania.
    Cannas A; Paglia MG; Sakhoo DC; Vairo F; Doulla B; Nguhuni B; Chaula Z; Mlumba R; Mirrione M; Bevilacqua N; Nicastri E; De Nardo P; Meschi S; Girardi E; Racalbuto V; Ippolito G
    J Infect Dev Ctries; 2013 Sep; 7(9):676-9. PubMed ID: 24042104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-line flagging monitoring - a new quality management tool for the analytical phase.
    Goossens K; Brinkmann T; Thienpont LM
    Clin Chem Lab Med; 2015 Sep; 53(10):e269-70. PubMed ID: 25898395
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization management: a European perspective.
    Plebani M; Zaninotto M; Faggian D
    Clin Chim Acta; 2014 Jan; 427():137-41. PubMed ID: 23499570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory oversight for research tests and laboratory-developed diagnostics should be more nimble.
    Berry DM; Parekh RS; Irwin MS
    CMAJ; 2019 Dec; 191(50):E1388. PubMed ID: 31844025
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory-developed tests are not the practice of medicine.
    Allen JS
    MLO Med Lab Obs; 2015 Sep; 47(9):46. PubMed ID: 26495599
    [No Abstract]   [Full Text] [Related]  

  • 17. Yearly Clinical Laboratory Test Expenditures for Different Medical Specialties in a Major Canadian City.
    Naugler C; Thomas R; Turin TC; Guo M; Vaska M;
    Am J Clin Pathol; 2015 Jul; 144(1):97-102. PubMed ID: 26071467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges of sexually transmitted infections in resource-limited settings.
    Peeling RW; Ronald A
    Future Microbiol; 2009 Dec; 4(10):1271-82. PubMed ID: 19995188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. College of american pathologists proposal for the oversight of laboratory-developed tests.
    Vance GH
    Arch Pathol Lab Med; 2011 Nov; 135(11):1432-5. PubMed ID: 22032569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An Accurate Diagnosis is Possible with a Systematic Analysis of Routine Laboratory Data].
    Yonekawa O
    Rinsho Byori; 2015 Sep; 63(9):1072-9. PubMed ID: 26731896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.